Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

酚磺乙胺片 - NMPA Drug Approval Details

Approvals/NMPA/Etamsylate Tablets

Approved

化学药品

Etamsylate Tablets

贵阳制药厂🇨🇳 National Medical Products Administration

Approval Date: May 31, 2003
Approval ID: 7zxQG202wSn
Company: 贵阳制药厂
Type: 化学药品

Approval Details

Approval Id: 7zxQG202wSn
Approval Number: 国药准字H52020843
Generic Name: 酚磺乙胺片
Generic Name En: Etamsylate Tablets
Drug Type: 化学药品
Strength: 0.25g
Reg Date: 2003-05-31
Company Name: 贵阳制药厂
Production Company Address: 贵阳市永安寺街29号
Company Detail Path: /organization/gui-yang-zhi-yao-han

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

May 31, 2003

Approval ID

7zxQG202wSn

Type

化学药品

Back to NMPA Approvals